Acknowledgement

Jointly provided by Postgraduate Institute for Medicine and RME Collaborative.

In collaboration with the Southeast AIDS Education & Training Center.

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

Credit Available

• Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
• Nurses — 1.0 Contact Hour (0.75 contact hour of pharmacotherapy credit)
• Pharmacists — 1.0 Contact Hour

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed specifically for primary care clinicians, nurses, pharmacists, and other members of the healthcare team who serve patients in rural and underserved communities.

Program Overview

Recent advances in antiretroviral therapy have markedly improved care and outcomes for patients living with HIV. This case-based activity, which is Part 3 of a four-part series titled HIV Management in Rural and Underserved Communities: Tailoring Care and Treatment to Improve Health Equity, will demonstate best practices for selecting an appropriate HIV treatment regimen and conducting ongoing testing and monitoring. Current guideline recommendations and new evidence to support early initiation of antiretroviral therapy will also be discussed.

This activity is a recording from a webinar series that took place in August 2022. Please note that any data, information, and guidance presented in the activity are subject to change.

Learning Objectives

Upon completion of this activity, participants should be better able to:  

• Apply best practices and evidence-based interventions to improve rapid HIV treatment initiation in rural and underserved settings
• Integrate evolving evidence and current guidelines to inform treatment decisions, patient monitoring, and adherence

Faculty

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, MA



Stephen P. Raffanti, MD, MPH
Professor of Medicine, Division of Infectious Diseases
Vanderbilt University School of Medicine
Founder
Vanderbilt Comprehensive Care Clinic
Nashville, TN

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RME Collaborative. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.75 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. 
(Universal Activity Number - JA4008162-9999-22-475-H02-P)
Type of Activity: Application

For Pharmacists: Upon successfully completing the post-test with a score of 67% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine and RME Collaborative adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Postgraduate Institute for Medicine requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies (commercial interests). All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to Postgraduate Institute for Medicine policy. Postgraduate Institute for Medicine is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Faculty

Paul E. Sax, MD, has disclosed the following relevant financial relationships: scientific advisory board member/consultant for Gilead Sciences, Inc., GlaxoSmithKline/ViiV Healthcare, Janssen Pharmaceuticals, and Merck & Co., Inc.; research support from Gilead Sciences, Inc. and GlaxoSmithKline/ViiV Healthcare.

Stephen P. Raffanti, MD, MPH, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer 

The Postgraduate Institute for Medicine and RME Collaborative planners, managers, and reviewer have nothing to disclose.

Instructions for Participation and Credit

This activity is offered at no cost to participants. To receive CME credit, participants must:

1. Read the CME/CE information, including learning objectives and disclosure statements.
2. Complete the pre-test.
3. View the online activity.
4. Complete the post-test and evaluation form.

A post-test score of 67% or higher is required to obtain credit. Your certificate will be made available for immediate download.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

©RME Collaborative, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.

Media

Internet activity

Fee Information

There is no fee for this educational activity.

Contact Information

General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine at inquiries@pimed.com.